|
|
40
|
|
|
5642CC
|
|
|
CEFUROXIME 750MG IV/IM INJ (LDP/AHI)
|
|
|
CEFUROXIME
|
|
|
CEFUROXIME
|
|
|
10X750MG
|
|
|
BQ
|
|
|
9.13
|
|
|
0.91
|
|
|
750MG IV/IM
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
LDP
|
|
|
LABDHI PHARMA
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Yes
|
|
|
08120608
|
|
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
|
IV/IM
|
|
|
6
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|